Prices are updated after-hours
Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
symbols : RVNC    crawled date : 2022 - 01 - 19    save search
Revance Receives Clarity on Path to Resubmission of the BLA for DaxibotulinumtoxinA for Injection Following Type A Meeting with FDA
Published: 2022-01-18 (Crawled : 01:00) - biospace.com/
RVNC | $3.615 -1.23% 850K twitter stocktwits trandingview |
Health Technology
 | | O: 0.0% H: 0.0% C: 0.0%
fda xin injection submission resubmission
Gainers vs Losers
55% 45%

Top 10 Gainers
CZOO | $10.52 110.82% 10M twitter stocktwits trandingview |

CSSE 4 | $0.3181 108.86% 170M twitter stocktwits trandingview |
Consumer Services
BOF | $1.88 60.68% 98M twitter stocktwits trandingview |

AMST | $3.1 55.0% 66M twitter stocktwits trandingview |
Technology Services
LICN | $0.8592 53.43% 13M twitter stocktwits trandingview |

WIMI | $1.03 41.99% 15M twitter stocktwits trandingview |
Technology Services
MULN | News | $3.675 34.62% 11M twitter stocktwits trandingview |
Information
RILY | $28.605 31.7% 9.9M twitter stocktwits trandingview |
Finance
RBBN 4 | $3.305 28.6% 1.9M twitter stocktwits trandingview |
Electronic Technology
RCAT | $1.53 27.5% 2.9M twitter stocktwits trandingview |
Information
Your saved searches
Save your searches and get alerts when important news are released.